Artifacts in Nuclear Medicine with Identifying and resolving artifacts.
2009 H1N1 Influenza Vaccine
1. Working With The H1N1 Influenza Vaccine The single most effective way to prevent influenza disease is with influenza vaccine! Carolee’s Corner November 2009 MPCA [email_address]
2. • This power point is very limited in space - It covers only a small portion of the information available - Please check these websites frequently for updated information www.cdc.gov/flu www.michigan.gov/flu
3. Don’t let yourself become confused: Similarities between H1N1 Influenza Vaccine and Seasonal Flu vaccine Administration of both vaccines - if 6-35 mos old -- give 0.25mL per dose - if 3 yrs and older --give 0.5mL per dose Dosage Both vaccines packaged by manufacturer as - Pre-filled 0.25mL syringes - Pre-filled 0.5mL syringes - Multi-dose vials Presentations TIV of both vaccines given IM LAIV of both vaccines given intranasally Route of administration All influenza vaccine is to be stored in frig at 35 ° -46 ° F (2°-8°C) Label ALL flu vaccine very carefully in frig Storage Both vaccines come as - TIV (inactivated) - LAIV (live, attenuated) Types
4. Don’t let yourself become confused: (cont) Similarities between H1N1 Influenza Vaccine and Seasonal Flu vaccine YOU need to get both influenza vaccines to protect - Yourself - Your patients - Your family and friends Need for Health Care Personnel to give vaccinated Some are licensed for - only 6-35 mos old children - only 6 mos and older - only 2-49 years old - only 3 yrs and older - only 4 yrs and older - only 18 years and older Check very carefully that the person to whom you are giving a vaccine fits into the licensed age group for that vaccine! Influenza vaccines from all manufacturers are licensed only for specific age groups !!
5.
6. Priority Target Groups for H1N1 vaccine when vaccine is in limited supply • Remember: - Priority groups may change - As vaccine supply increases or decreases Yes, if 2 yrs of age and older, healthy, not preg. Yes Health care and emergency medical services personnel No Yes Persons 25 thru 64 yrs old with medical condition that puts them at high risk Yes, if 2 -49 yrs of age, healthy, not preg. Yes Persons living with or caring for infants less than 6 mos old Yes, if 2 yrs of age and older, healthy, not preg. Yes Persons 6 mos thru 24 yrs old No Yes Pregnant women Give LAIV? Give TIV? Priority Group
7. Which Seasonal Vaccines & H1N1 Vaccines can you give to a patient during the same visit? When giving Seasonal TIV and H1N1 TIV flu vaccines at the same time, administer vaccines in different sites Yes One inactivated and one live, attenuated vaccine: H1N1 TIV and Seasonal LAIV? No Two LAIV vaccines: Seasonal LAIV and H1N1 LAIV? Remember the Live-Live rule: If two live vaccines are not given at the same time, they must be separated by 28 days Yes One inactivated and one live, attenuated vaccine: Seasonal TIV and H1N1 LAIV? Yes Two inactivated vaccines: Seasonal TIV & H1N1 TIV ? Can these vaccines be given at the same time?
_________________________________________________________________________ FYI From the IAC Ask the Experts Q and A on Novel H1N1 Vaccine Q: Will we be able to administer both the seasonal and H1N1 influenza vaccines at the same visit? A: You can in most cases. See the points below. * You can administer both the inactivated seasonal and the inactivated H1N1 influenza vaccines at the same visit (using separate syringes and sites) or at any time before or after each other. * You can administer the inactivated seasonal and live H1N1 influenza vaccines together or at any time before or after each other. * You can administer the live seasonal and inactivated H1N1 influenza vaccines together or at any time before or after each other. * Administering both the live attenuated seasonal and the live attenuated H1N1 influenza vaccines at the same visit is NOT recommended because of concerns about competition between the two vaccine viruses. If you have only live vaccines for both seasonal and H1N1 influenza available, you should separate the doses of the two live vaccines by at least 4 weeks.
Reporting clinically significant adverse events following vaccination is true for all vaccines not just H1N1 _____________________________________________________ FYI VAERS website: www.vaers.hhs.gov
The risks associated with influenza are greater than any hypothetical risks associated with vaccine ______________________________________________________ FYI No scientific evidence indicates that thimerosal in vaccines, including influenza vaccines, is a cause of adverse events in vaccine recipients or to children born to women who received vaccine during pregnancy. In fact, evidence is accumulating that supports the absence of any risk for neurodevelopment disorders or other harm resulting from exposure to thimerosal-containing vaccines. The benefits of influenza vaccination for all recommended groups, including pregnant women and young children, outweigh the unproven risk from thimerosal exposure through vaccination. The risks for severe illness from influenza virus infection are elevated among both young children and pregnant women, and vaccination has been demonstrated to reduce the risk for severe influenza illness and subsequent medical complications. In contrast, no scientifically conclusive evidence has demonstrated harm from exposure to vaccine containing thimerosal preservative. For these reasons, persons recommended to receive TIV may receive any age- and risk factor–appropriate vaccine preparation, depending on availability. ACIP and other federal agencies and professional medical organizations continue to support efforts to provide thimerosal preservative–free vaccine options. Prevention and Control of Influenza Recommendations of the ACIP MMWR August 8, 2008 .
________________________________________________________ FYI Information current as of Sept 2, 2009 from the CDC website www.cdc.gov/h1n1flu- vaccine Q and A
![Working With The H1N1 Influenza Vaccine The single most effective way to prevent influenza disease is with influenza vaccine! Carolee’s Corner November 2009 MPCA [email_address]](https://image.slidesharecdn.com/2009-11h1n1influenzavaccine-091026123137-phpapp01/85/2009-H1N1-Influenza-Vaccine-1-320.jpg)
